A novel electrospun nano-fabric graft allows early cannulation access and reduces exposure to central venous catheters

Journal of Vascular Access

Volumn 14, Issue 3, 2013, Pages 273-280

  Karatepe, Celalettin ^a   Aitinay, Levent ^a   Yetim, Tulin Durgun ^a   Dagli, Celalettin ^b   Dursun, Suat ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b Antakya Devlet Hastanesi   (Turkey)

Author keywords

Arterio venous access; Clinical study; Early access; Electrospinning; Hemodialysis graft; Nano fabric; Polycarbonate urethane

Indexed keywords

HEPARIN; POLYCARBONATE; URETHAN;

ADULT; ARTERIOVENOUS FISTULA; ARTICLE; CANNULATION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; ELECTROSPINNING; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; INFECTION RATE; MALE; RETROSPECTIVE STUDY; SURVIVAL; THROMBECTOMY; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NANOSTRUCTURES; POLYCARBOXYLATE CEMENT; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; PUNCTURES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; URETHANE; VASCULAR PATENCY; YOUNG ADULT;

EID: 84885804556     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/jva.5000145     Document Type: Article

References (26)

1. Ethier J, Mendelssohn DC, Elder SJ, et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2008;23(10):3219-3226.
2. Wijeyaratne SM, Kannangara L. Safety and efficacy of electrospun polycarbonate-urethane vascular graft for early hemodialysis access: first clinical results in man. J Vasc Access. 2011;12(1):28-35.
3. Slayden GC, Spergel L, Jennings WC. Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access. Semin Dial. 2008;21(5):474-482.
4. Sidawy AN, Gray R, Besarab A, et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg. 2002;35(3):603-610.
5. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy and Vascular Access. Am J Kidney Dis 2006;48(suppl 1):S1-S322. Also available at: http://www.kidney.org/professionals/kdoqi/pdf/12-50-0210_JAG_DCP_Guidelines-VA_Oct06_SectionC_ofC.pdf.
6. Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med. 1966;275(20): 1089-1092.
7. Tordoir J, Canaud B, Haage P, et al. EBPG on vascular access. Nephrol Dial Transplant. 2007;22(Suppl 2): ii88-ii117.
8. Biuckians A, Scott EC, Meier GH, Panneton JM, Glickman MH. The natural history of autologous fistulas as first-time dialysis access in the KDOQI era. J Vasc Surg. 2008;47(2):415-421, discussion 420-421.
9. Saran R, Dykstra DM, Pisoni RL, et al. Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS. Nephrol Dial Transplant. 2004;19(9):2334-2340.
10. Schwab SJ, Beathard G. The hemodialysis catheter conundrum: hate living with them, but can't live without them. Kidney Int. 1999;56(1):1-17.
11. Roberts TL, Obrador GT, St Peter WL, Pereira BJ, Collins AJ. Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients. Kidney Int. 2004;66(6):2429-2436.
12. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62(2):620-626.
13. Collins AJ, Foley RN, Gilbertson DT, Chen SC. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009;4(Suppl 1):S5-S11.
14. Wasse H, Speckman RA, Frankenfield DL, Rocco MV, Mc-Clellan WM. Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients. Am J Kidney Dis. 2007;49(2):276-283.
15. Akoh JA. Prosthetic arteriovenous grafts for hemodialysis. J Vasc Access. 2009;10(3):137-147.
16. Dixon BS, Beck GJ, Vazquez MA, et al; DAC Study Group. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med. 2009;360(21):2191-2201.
17. Rooijens PP, Burgmans JP, Yo TI, et al. Autogenous radialcephalic or prosthetic brachial-antecubital forearm loop AVF in patients with compromised vessels? A randomized, multicenter study of the patency of primary hemodialysis access. J Vasc Surg. 2005;42(3):481-486, 487.
18. Keuter XH, De Smet AA, Kessels AG, van der Sande FM, Welten RJ, Tordoir JH. A randomized multicenter study of the outcome of brachial-basilic arteriovenous fistula and prosthetic brachial-antecubital forearm loop as vascular access for hemodialysis. J Vasc Surg. 2008;47(2): 395-401.
19. Kakkos SK, Topalidis D, Haddad R, Haddad GK, Shepard AD. Long-term complication and patency rates of Vectra and IMPRA Carboflo vascular access grafts with aggressive monitoring, surveillance and endovascular management. Vascular. 2011;19(1):21-28.
20. Kakkos SK, Andrzejewski T, Haddad JA, et al. Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment. J Vasc Surg. 2008;47(2):407-414.
21. Chemla ES, Nelson S, Morsy M. Early cannulation grafts in straight axillo-axillary angioaccesses avoid central catheter insertions. Semin Dial. 2011;24(4):456-459.
22. Schild AF, Schuman ES, Noicely K, et al. Early cannulation prosthetic graft (Flixene™) for arteriovenous access. J Vasc Access. 2011;12(3):248-252.
23. Lioupis C, Mistry H, Rix T, Chandak P, Tyrrell M, Valenti D. Comparison among transposed brachiobasilic, brachiobrachial arteriovenous fistulas and Flixene™ vascular graft. J Vasc Access. 2011;12(1):36-44.
24. Allon M, Lok CE. Dialysis fistula or graft: the role for randomized clinical trials. Clin J Am Soc Nephrol. 2010; 5(12):2348-2354.
25. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S. Canadian Hospital Epidemiology Committee. Canadian Nosocomial Infection Surveillance Program. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol. 2002;23(12):716-720.
26. Grudzinski L, Quinan P, Kwok S, Pierratos A. Sodium citrate 4% locking solution for central venous dialysis catheters-an effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant. 2007;22(2):471-476.